FR2128267A1 - Anti-cancer medicament - contg mumps viruses from saliva of patients - Google Patents

Anti-cancer medicament - contg mumps viruses from saliva of patients

Info

Publication number
FR2128267A1
FR2128267A1 FR7129864A FR7129864A FR2128267A1 FR 2128267 A1 FR2128267 A1 FR 2128267A1 FR 7129864 A FR7129864 A FR 7129864A FR 7129864 A FR7129864 A FR 7129864A FR 2128267 A1 FR2128267 A1 FR 2128267A1
Authority
FR
France
Prior art keywords
saliva
patients
contg
mumps
cancer medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7129864A
Other languages
English (en)
French (fr)
Other versions
FR2128267B1 (2
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASADA TERUO JA
Original Assignee
ASADA TERUO JA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ASADA TERUO JA filed Critical ASADA TERUO JA
Publication of FR2128267A1 publication Critical patent/FR2128267A1/fr
Application granted granted Critical
Publication of FR2128267B1 publication Critical patent/FR2128267B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18732—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR7129864A 1971-03-09 1971-08-16 Anti-cancer medicament - contg mumps viruses from saliva of patients Granted FR2128267A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1258771 1971-03-09

Publications (2)

Publication Number Publication Date
FR2128267A1 true FR2128267A1 (en) 1972-10-20
FR2128267B1 FR2128267B1 (2) 1975-02-07

Family

ID=11809473

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7129864A Granted FR2128267A1 (en) 1971-03-09 1971-08-16 Anti-cancer medicament - contg mumps viruses from saliva of patients

Country Status (4)

Country Link
DE (1) DE2154202A1 (2)
DK (1) DK127457B (2)
FR (1) FR2128267A1 (2)
NL (1) NL7111160A (2)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000003733A1 (en) * 1998-07-16 2000-01-27 Vincent Marinkovich Methods and compositions for cancer treatment

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2009119A1 (en) 1993-04-30 2008-12-31 Wellstat Biologics Corporation Compositions for treating cancer using viruses

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000003733A1 (en) * 1998-07-16 2000-01-27 Vincent Marinkovich Methods and compositions for cancer treatment

Also Published As

Publication number Publication date
DK127457B (da) 1973-11-12
FR2128267B1 (2) 1975-02-07
DE2154202A1 (de) 1972-09-14
NL7111160A (2) 1972-09-12

Similar Documents

Publication Publication Date Title
ES2103276T3 (es) Composicion para la activacion del sistema inmunitario.
GB1213004A (en) Improved surgical drainage apparatus
IL40495A0 (en) Poly 2'-fluoro-2'-deoxyuridylic acid,its preparation and its use as an enzyme inhibitor
ATA1054472A (de) Ventil fuer zahnaerztliche handstuecke, bei- spielsweise fuer bohr-, spritz- und saug- handstuecke
BE770323A (fr) Preparation de pancreatine, sans germes et s'ecoulant facilement et procede pour sa preparation
IT946151B (it) Dializzatore in particolare per la purificazione del sangue
AU470383B2 (en) Hemodialyzer with tapered slip blood ports and baffles
ZA733736B (en) And medical purposes improvements in or relating to tubes for surgical
CA968243A (en) Cutting and dilating surgical device
FR2128267A1 (en) Anti-cancer medicament - contg mumps viruses from saliva of patients
FR2134292A1 (en) Interferon compsns - contg halo desoxyuridines rifamycine or rifampycine
IT1057861B (it) Composizione per la diagnosi ed il trattamento di infezioni microbiche
CA815315A (en) Veterinary and medical vaginal treatment instrument
Kleinsasser Solitary pyogenic abscess of the left lobe of the liver
OA04927A (fr) Nouveaux dérivés de l'Amino-propanediol, leur procédé de préparation et leurs applications en thérapeutique humaine.
FR2077790A1 (en) Anti-rheumatism medicament - contg butylsalicylamine and ethyl salicylamide
SE404990B (sv) Forfarande for konservering av menniskoblod och konserverande losning for genomforande av forfarandet
TAMAI et al. Studies on tissue concentration of antibiotics in the field dental and oral surgery V. Basic experiment on concentration of carbenicillin in the jaw bone
KARAMCHANDANI et al. or alternatively pus cells comparatively more
GB1036059A (en) Improvements in or relating to the inhibition of bacterial growth
OA04926A (fr) Procédé de fabrication d'adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, à partir de mycobactéries et micro-organismes apparentés.
Olivo et al. Malignancy-associated Sweet's syndrome: Review of the world literature
BE757336A (en) 5-butyl-and5-pentyl-picolinic acids active - as dopamene-b-hydroxylase inhibitors
GUL'MURADOV et al. CLINICAL CHARACTERISTICS OF TYPHOID FEVER IN CHILDREN IN EPIDEMIC WATER-BORNE INFECTION
Del Guercio Advances in physiologic sensing

Legal Events

Date Code Title Description
ST Notification of lapse